Movement-2-Music Exercise Program for Mobility Disabilities
(M2M LEADERS Trial)
Trial Summary
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It is best to discuss this with the trial coordinators or your doctor.
What data supports the effectiveness of the Movement-2-Music treatment for mobility disabilities?
The Movement-2-Music program is designed to be enjoyable and accessible for people with physical disabilities, addressing common barriers like transportation and time. Similar structured physical activity programs have shown benefits in improving mobility and reducing disability in older adults, suggesting potential effectiveness for this treatment.12345
Is the Movement-2-Music Exercise Program safe for people with mobility disabilities?
How is the Movement-2-Music treatment different from other treatments for mobility disabilities?
The Movement-2-Music treatment is unique because it is a home-based exercise program that combines rhythmic music with movement, making it enjoyable and accessible for people with mobility disabilities. Unlike traditional exercise programs, it is delivered remotely, eliminating barriers like transportation and time commitment, and is tailored to individual functional levels.1791011
What is the purpose of this trial?
The purpose of this study is to test the effects of an innovative exercise program referred to as movement-2-music (M2M) on health and fitness outcomes in adults with physical/mobility disabilities. One hundred and eight participants with physical/mobility disabilities will be recruited and randomly enrolled into one of two groups: a) M2M or b) waitlist control. The primary aim of this study is to determine the effects of a 12-week M2M program on health and fitness in participants with physical/mobility disabilities who are in one of three functional mobility groups: 1) Group I - only able to exercise while sitting, 2) Group II - able to exercise sitting and standing with/without support, and 3) Group III - able to exercise one side of the body more than the other side. The second aim is to compare the observed effects of the program in this study to a previous M2M study that groups participants based on disability type. The third aim of this study is to test whether adherence (defined as attendance to the 12-week program) affects the effects of M2M in participants with physical/mobility disabilities. The potential influences of different functional mobility and disabilities of participants on how the program affects participants' health and fitness outcomes will also be tested.\*\*In response to COVID-19, the 12-week M2M intervention and all assessments have been modified from being delivered in-person at Lakeshore Foundation to being delivered remotely in real-time through videoconferencing technology.\*\*
Eligibility Criteria
This trial is for adults with physical disabilities like multiple sclerosis, traumatic brain injury, cerebral palsy, spinal cord injury, Parkinson's disease, stroke or spina bifida. Participants must be able to exercise using their limbs and follow instructions in English. They need a doctor's approval to join but can't take part if they have significant hearing loss, poor vision that affects group activities, recent smoking history or cognitive impairments.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants engage in a 12-week eM2M intervention with three 60-minute sessions per week delivered remotely
Follow-up
Participants are monitored for health and fitness outcomes through assessments every 6 months and annually for up to 5 years
Treatment Details
Interventions
- Movement-2-Music
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Alabama at Birmingham
Lead Sponsor
Lakeshore Foundation
Collaborator
YMCA of Greater Birmingham
Collaborator